Schedule Your Consultation Today! Phone (561) 367-9101 First Name Last Name Phone Email Sign up for cosmetic surgery news and receive a $25 gift certificate to SMAC!

May 2009

The Food and Drug Administration has just announced final approval for the brand new    competition to Botox Cosmetic, Dysport, from the makers of Restylane & Perlane. Dysport (formerly called Reloxin in the FDA Study), has been used to treat wrinkles in the UK and Europe for several years, and will be available in our office in 30-60 days. Keep an eye out for your exclusive invitaiton to be one of the first to experience this exciting new treatment, when we offer  a one-day-only savings oppurtunity to celebrate the official release of Dysport!

Don't miss exciting news at SMAC! Sign up for our e-newsletter to recieve special offers and cosmetic news.


March 2009

Now you can grow longer, fuller dark lashes with LATISSE, the first FDA approved prescription eyelash treatment. LATISSE makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is not known, research suggests that the growth of eyelashes occurs by increasing the percent of hairs in, and the duration of, the anagen (or growth) phase. Lashes can grow longer, thicker and darker because bimatoprost can also prolong this growth phase.

Relaxed Expressions Study

Do you wish that you didn't have to return to the spa every few months for a dose of Botox? Relaxed Expressions could be the answer! A non-surgical, non-toxic method of reducing frown lines, Relaxed expressions is FDA approved and requires treatment every 12-18 months. SMAC is currently looking for patients to participate in the study.
Good Candidates Include:

• Patients who have not had a Botox treatment in 4-6 months.
• Patients who want to improve the appearance of their glabellar lines.
• Patients who do not want to receive a toxin or are non-responders to toxins.
• Patients with toxin fatigue.
• Patients undergoing additional surgical procedures such as brow lifts.

You cannot participate in this study if you have the following conditions:

• Pacemaker or defibrillator.
• Uncontrolled diabetes.
• Seizure disorder.
• Pregnant.

If you do not have any of the conditions above, please contact Angel at 561-866-0970 to see if you are a candidate for the study.